Trends in phase III randomized controlled clinical trials on the treatment of advanced non‐small‐cell lung cancer-Reference-Cited by-同舟云学术

Trends in phase III randomized controlled clinical trials on the treatment of advanced non‐small‐cell lung cancer

Published:2016-07-23 Issue:9 Volume:5 Page:2190-2197
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Fernández‐López Cristina¹,Expósito‐Hernández José²,Arrebola‐Moreno Juan Pedro²,Calleja‐Hernández Miguel Ángel¹,Expósito‐Ruíz Manuela³,Guerrero‐Tejada Rosa²,Linares Isabel²,Cabeza‐Barrera José¹

Affiliation:

1. Department of Pharmacy Biosanitary Institute of Granada (ibs.GRANADA) University Hospitals of Granada/University of Granada Granada Spain

2. Department of Oncology Virgen de las Nieves Universitary Hospital Granada Spain

3. Unit Research Support Biosanitary Institute of Granada (ibs.GRANADA) University Hospitals of Granada/University of Granada Granada Spain

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.782

Reference33 articles.

1. Lung cancer: epidemiology, etiology, and prevention;Tanoue L. T.;Clin. Chest Med.,2011

2. The epidemiology of lung cancer in china;Chen W.;J. Cancer Biol. Res.,2014

3. Ferlay J. I.Soerjomataram M.Ervik R.Dikshit S.Eser andC.Mathers et al.2013.GLOBOCAN 2012 v1.0 Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon France: International Agency for Research on Cancer. p.1–10. Available atwww.globocan.iarc.fr(accessed on 17 February 2015).

4. Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy

5. Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes of First-line Therapies for Advanced Non–Small Cell Lung Cancer;American Journal of Clinical Oncology;2023-07-31

2. Recent Developments and Challenges in Molecular-Targeted Therapy of Non-Small-Cell Lung Cancer;Journal of Environmental Pathology, Toxicology and Oncology;2023

3. Patient-Reported Outcomes in Lung Cancer;Medical Radiology;2022

4. The State of the Science in Patient-Reported Outcomes for Patients with Lung Cancer;Seminars in Respiratory and Critical Care Medicine;2020-05-25

5. Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation;European Journal of Medicinal Chemistry;2020-03